Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective

Abstract Background This study aimed to estimate the economic burden of community-acquired pneumonia (CAP) among elderly patients in Japan. In addition, the study evaluated the relationship between total treatment cost and CAP risk factors. Methods An administrative database was searched for elderly...

Full description

Bibliographic Details
Main Authors: Keiko Konomura, Hideaki Nagai, Manabu Akazawa
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Pneumonia
Subjects:
Online Access:http://link.springer.com/article/10.1186/s41479-017-0042-1
_version_ 1811221865830547456
author Keiko Konomura
Hideaki Nagai
Manabu Akazawa
author_facet Keiko Konomura
Hideaki Nagai
Manabu Akazawa
author_sort Keiko Konomura
collection DOAJ
description Abstract Background This study aimed to estimate the economic burden of community-acquired pneumonia (CAP) among elderly patients in Japan. In addition, the study evaluated the relationship between total treatment cost and CAP risk factors. Methods An administrative database was searched for elderly patients (≥ 65 years old) who had pneumonia (ICD-10 code: J12–J18) and an antibiotic prescription between 1 June 2014 and 31 May 2015. The all-cause total healthcare costs of outpatient and inpatient CAP episodes were calculated. Results This study evaluated data from 29,619 patients with CAP who experienced 14,450 outpatient CAP episodes and/or 20,314 inpatient CAP episodes. The mean ages were 77.5 ± 8.0 years and 81.5 ± 8.2 years among the outpatient and inpatient groups, respectively. The median treatment costs were US$346 (interquartile range: $195–551) per outpatient episode and US$4851 (interquartile range: $3313–7669) per inpatient episode. More severe cases had increased treatment costs at the treating hospitals. Male sex, diabetes, chronic obstructive pulmonary disease, and liver dysfunction were associated with increased total treatment costs, while dementia, dialysis, and rheumatism were associated with high costs of treating a CAP episode. Conclusions The economic burden of CAP might be decreased by reducing the number of hospitalizations for mild CAP and the incidence of severe CAP. Therefore, preventative care (e.g. oral hygiene or pneumococcus vaccination) is recommended for patients with related risk factors, such as male sex, older age, diabetes, chronic obstructive pulmonary disease, liver dysfunction, rheumatism, dementia, or dialysis.
first_indexed 2024-04-12T08:07:34Z
format Article
id doaj.art-227ea1accb0a4cb3ac645f1e3a4fd1ae
institution Directory Open Access Journal
issn 2200-6133
language English
last_indexed 2024-04-12T08:07:34Z
publishDate 2017-12-01
publisher BMC
record_format Article
series Pneumonia
spelling doaj.art-227ea1accb0a4cb3ac645f1e3a4fd1ae2022-12-22T03:41:06ZengBMCPneumonia2200-61332017-12-019111010.1186/s41479-017-0042-1Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspectiveKeiko Konomura0Hideaki Nagai1Manabu Akazawa2Public Health and Epidemiology, Meiji Pharmaceutical UniversityCenter for Pulmonary Diseases, National Hospital Organization Tokyo National HospitalPublic Health and Epidemiology, Meiji Pharmaceutical UniversityAbstract Background This study aimed to estimate the economic burden of community-acquired pneumonia (CAP) among elderly patients in Japan. In addition, the study evaluated the relationship between total treatment cost and CAP risk factors. Methods An administrative database was searched for elderly patients (≥ 65 years old) who had pneumonia (ICD-10 code: J12–J18) and an antibiotic prescription between 1 June 2014 and 31 May 2015. The all-cause total healthcare costs of outpatient and inpatient CAP episodes were calculated. Results This study evaluated data from 29,619 patients with CAP who experienced 14,450 outpatient CAP episodes and/or 20,314 inpatient CAP episodes. The mean ages were 77.5 ± 8.0 years and 81.5 ± 8.2 years among the outpatient and inpatient groups, respectively. The median treatment costs were US$346 (interquartile range: $195–551) per outpatient episode and US$4851 (interquartile range: $3313–7669) per inpatient episode. More severe cases had increased treatment costs at the treating hospitals. Male sex, diabetes, chronic obstructive pulmonary disease, and liver dysfunction were associated with increased total treatment costs, while dementia, dialysis, and rheumatism were associated with high costs of treating a CAP episode. Conclusions The economic burden of CAP might be decreased by reducing the number of hospitalizations for mild CAP and the incidence of severe CAP. Therefore, preventative care (e.g. oral hygiene or pneumococcus vaccination) is recommended for patients with related risk factors, such as male sex, older age, diabetes, chronic obstructive pulmonary disease, liver dysfunction, rheumatism, dementia, or dialysis.http://link.springer.com/article/10.1186/s41479-017-0042-1Community-acquired pneumoniaEconomic burden of diseaseCost analysisA-DROP systemInvasive pneumococcal diseasePneumonia
spellingShingle Keiko Konomura
Hideaki Nagai
Manabu Akazawa
Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective
Pneumonia
Community-acquired pneumonia
Economic burden of disease
Cost analysis
A-DROP system
Invasive pneumococcal disease
Pneumonia
title Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective
title_full Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective
title_fullStr Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective
title_full_unstemmed Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective
title_short Economic burden of community-acquired pneumonia among elderly patients: a Japanese perspective
title_sort economic burden of community acquired pneumonia among elderly patients a japanese perspective
topic Community-acquired pneumonia
Economic burden of disease
Cost analysis
A-DROP system
Invasive pneumococcal disease
Pneumonia
url http://link.springer.com/article/10.1186/s41479-017-0042-1
work_keys_str_mv AT keikokonomura economicburdenofcommunityacquiredpneumoniaamongelderlypatientsajapaneseperspective
AT hideakinagai economicburdenofcommunityacquiredpneumoniaamongelderlypatientsajapaneseperspective
AT manabuakazawa economicburdenofcommunityacquiredpneumoniaamongelderlypatientsajapaneseperspective